RecruitingNot ApplicableNCT04820764
EFS of the CardioMech MVRS
Early Feasibility Study of the CardioMech Mitral Valve Repair System (MVRS)
Sponsor
CardioMech AS
Enrollment
25 participants
Start Date
Jul 27, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called CardioMech MVRS for people with mitral regurgitation. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECardioMech MVRS
CardioMech MVRS
Locations(12)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04820764
Related Trials
Capstan Medical TMVR Study: FIH
NCT066001913 locations
A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System
NCT074509113 locations
Cephea Early Feasibility Study
NCT0506100422 locations
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
NCT0549699837 locations
The CardioClip Study
NCT062414301 location